DMG activity (Service) – yearly aims and objectives, special arrangements to achieve these, any audit report, OPD timings, surgery days etc. other information relevant to patients and referring doctors.
The thoracic oncology DMG is amongst the few specialized multidisciplinary thoracic oncology groups in the country treating a wide variety of lung, esophageal, chest wall and mediastinal tumors.
A team of experts from different specialties customize the management of patients by designing the most effective combination of Surgery, Radiation therapy, Chemotherapy and Radiology & Pulmonary Medicine to suit the individual’s needs in a multi disciplinary Joint Clinic (JC) which is held on every Monday and Wednesday . All newly diagnosed patients as well as patients who have undergone a complete staging evaluation are usually evaluated during this clinic. These management decisions are based on evidence but tailored to the individual patient.
Surgical Oncology: Monday and Wednesday 9.30 to 5.30 PM
Radiation Oncology: Monday to Friday 9.30 to 5.30 PM
Medical Oncology: Monday to Friday 9.30 to 5.30 PM
OT Days- Tuesday, Thursday & Friday
Pulmonary Medicine: Monday to Friday ( Except Wednesday ) 8 am to 1 pm
Thoracic JC: Monday & Wednesday 12:30 to 3:00 pm.
High Risk JC The initiation of the “high-risk” multidisciplinary meeting with thoracic surgeons, anesthesiologists, critical care specialists and pulmonary physicians, a unique feature of the DMG has led to increasing numbers of high-risk patients being considered for surgery with the aim of improving outcomes, optimizing the care of patients with multiple comorbidities prior to surgery. Active participation from the physiotherapy department on postoperative rounds ensures individualized attention to specific patient needs over and above the routine.
Lung & Esophagus Cancer Support group meeting: Esophageal and lung cancer support group meeting is held on 4th Tuesday of every month. It has invited talks, discussions focusing on patient-centric problems. The involvement from patients has been encouraging and this provides them a forum for exchange of experiences, discussing their fears, concerns and closer interaction with other patients and their treating physicians. In addition, the availability of dedicated counselors for patients with thoracic cancers and the institution of early palliative care into the treatment continuum are some more initiatives to improve the overall experience for patients.
Management of complex airway problems including tracheobronchial stenting and laser therapy
Evidence based management of advanced lung and esophageal cancers with molecular-based personalized targeted therapy and chemotherapy
State of the art radiotherapy services include tomotherapy, image-guid ed and stereotactic body radiotherapy
Immediate postoperative, post chemotherapy and radiation therapy outcomes comparable with similar high volume centers in the world.
In addition to the above the DMG also has a very effective program for palliation of both advanced esophageal and lung cancers, with early involvement of the palliative care team
The Pulmonary Medicine Unit has proposed a 2 year academic programme towards Fellowship in Onco-Pulmonology for Chest Physicians through Homi Bhabha National Institute (HBNI) that is currently awaiting approval by the Board of Studies for academic year 2018-2019.
The DMG conducts dedicated teaching sessions and on-the job training for the MCh (Surgical Oncology), DM (Medical Oncology) and MD (Radiation Oncology) courses. In addition, a two-year fellowship in thoracic surgical oncology is offered under the Homi Bhabha National Institute and is the only one of its kind in the country. The teaching programme is highly structured and includes didactic lectures, seminars and case-presentations. Regular orientation lectures are taken for all new registrars and fellows working in thoracic surgery nine times a year. Two comprehensive CMEs were conducted covering the entire spectrum of lung cancer which was attended by postgraduates, residents and fellows from across the country. A lung practicum was conducted in the department of radiation oncology, a limited hands-on course focusing especially on stereotactic radiotherapy in lung cancers.
The DMG has several trainees - ten thoracic surgical fellows (two 2-year fellowships, two one-year fellowships and six 6-month fellowships); twelve senior MCh (Surg Onco) registrars, fifteen junior MCh (Surg Onco) registrars, six medical and twelve radiation oncology registrars rotate through the DMG every year. In addition, training is provided in diagnostic bronchoscopy to 24 physicians from across the country annually.
We also conduct:
Case capsules: Every Monday and Wednesday in surgical oncology department.
Difficult Case Discussion : Tuesday & Thursday in Medical oncology department.
The DMG is amongst the highest volume thoracic cancer referral centers in the world. A total of 3802 new patients, comprising over 10% of the hospital registrations were registered in the DMG in 2014, of which 2,263 (59.6%) were general and 1537 (40.4%) were private patients. Lung cancers were the majority, 2374 (62.4%) followed by esophageal cancer 1070 (28.1%).
The thoracic surgical unit is the highest volume thoracic oncology centre in India and operated 197 patients with esophageal cancer, 104 patients with lung cancer, 145 patients with pulmonary metastases, 35 patients with mediastinal tumors and 32 patients with chest wall tumors. In addition, several minor procedures including diagnostic and therapeutic bronchoscopy, port insertions, intercostal drainage, pleurodesis etc were performed. Early post-operative outcomes are comparable with most high volume centres in the world. A large number of patients are operated by minimally invasive surgery including thoracoscopy, laparoscopy and robotic surgery.
The thoracic medical oncology unit has amongst the highest volumes in the country and treated 1414 patients with lung cancer and 503 patients with esophageal cancer. These include neoadjuvant, adjuvant and palliative chemotherapy including targeted therapy. Overall response rates, toxicity and survival figures were similar to high quality thoracic oncology centres worldwide.
Thoracic radiation oncology treated 503 patients with lung cancer with compliance of 98% and 77 patients with esophageal cancer with a compliance rate of 91 percent. Short and medium term outcomes have been meticulously documented and periodic audits conducted to monitor performance critically. All modern techniques of radiation including IGRT, IMRT, 3DCRT and SBRT are available and used regularly to provide superior treatment outcomes.
Development of guidelines, scientific report, educational modules, etc: The guidelines for the treatment were last updated in the Evidence Based Management Guideline Meeting on Thoracic cancers held in February-March 2013. In addition any updates in literature that warrant a change in the management guidelines are also taken into account. An annual report including the annual activities of the DMG and DMG members is compiled every year.
The DMG maintains ongoing quality improvement measures with continuous audits of peri-operative, post chemotherapy and post radiotherapy morbidity and mortality estimation with emphasis on post operative infections and treatment compliance
The thoracic DMG conducts several investigator-initiated and sponsored research studies. Practice changing studies in the Thoracic DMG
The thoracic DMG is involved in the conduct of several investigator-initiated and sponsored research studies. Some of the studies initiated earlier were published and presented in high impact journals and international conferences respectively. The randomized trial evaluating the role of perioperative erythromycin to prevent delayed gastric emptying in patients undergoing esophagectomy was presented in the biennial conference of the International Society for Diseases of the Esophagus in Vancouver. Ongoing randomized trials include the trials comparing radical three-field vs two field esophagectomy for operable esophageal cancer, and neoadjuvant chemotherapy with neoadjuvant chemoradiation for locoregionally advanced esophageal cancer. In addition, several new studies were initiated this year and planned for the next year.
The CHEST (Cancers of the Hypopharynx and Esophagus Trial) screening trial is underway in Ratnagiri district with over 33000 individuals having been screened and given health awareness for upper aerodigestive tract cancers. Extensive health education and awareness of health hazards of tobacco use is an integral part of the programme. Several other randomized trials are underway in advanced lung and esophageal cancers. Several articles have been published by DMG members in various peer reviewed journals.
Staff Publications 2015-2017 |
||||
Thoracic Department |
Sr.no. |
Title |
Description |
Details |
Identifiers |
1 |
Chemotherapy for resected colorectal cancer pulmonary metastases: Utilization and outcomes in routine clinical practice. | Karim S, Nanji S, Brennan K, Pramesh CS, Booth CM. | Eur J Surg Oncol. 2017 Aug;43(8):1481-1487. doi: 10.1016/j.ejso.2017.05.003. Epub 2017 Jun 1. | PMID:28634014 |
2 |
Extent of Lymphadenectomy in Operable Esophageal Cancer. | Shetty PS, Sawant A, Mankar H, Pramesh CS. | Ann Thorac Surg. 2017 Jul;104(1):375. doi: 10.1016/j.athoracsur.2016.06.101. No abstract available. | PMID:28633241 |
3 |
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks. | Del Paggio JC, Sullivan R, Schrag D, Hopman WM, Azariah B, Pramesh CS, Tannock IF, Booth CM. | Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2. | PMID:28583794 |
4 |
Common pitfalls in statistical analysis: Logistic regression. | Ranganathan P, Pramesh CS, Aggarwal R. | Perspect Clin Res. 2017 Jul-Sep;8(3):148-151. doi: 10.4103/picr.PICR_87_17. | PMID:28828311 | PMCID:PMC5543767 |
5 |
Management of locally advanced primary mediastinal synovial sarcoma. | Chatterjee AS, Kumar R, Purandare N, Jiwnani S, Karimundackal G, Pramesh CS. | Lung India. 2017 Mar-Apr;34(2):185-188. doi: 10.4103/0970-2113.201295. | PMID:28360472 | PMCID:PMC5351366 |
6 |
Protective Lung Strategy During Bronchoscopic Laser Resection of Tracheobronchial Tumors: A Case Series. | Agarwal V, Parab SY, Pramesh CS. | J Cardiothorac Vasc Anesth. 2017 Feb 24. pii: S1053-0770(17)30245-8. doi: 10.1053/j.jvca.2017.02.183. [Epub ahead of print] No abstract available. | PMID:28587760 |
7 |
VATS Versus Open Lobectomy: Need for a Prospective Trial. | Sawant A, Mankar H, Chatterjee A, Pramesh CS. | Ann Thorac Surg. 2017 Feb;103(2):690-691. doi: 10.1016/j.athoracsur.2016.06.047. No abstract available. | PMID:28109362 |
8 |
Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9. | Balla MM, Desai S, Purwar P, Kumar A, Bhandarkar P, Shejul YK, Pramesh CS, Laskar S, Pandey BN. | Sci Rep. 2016 Nov 4;6:36065. doi: 10.1038/srep36065. | PMID:27811960 | PMCID:PMC5095766 |
9 |
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours. | Coyle C, Cafferty FH, Rowley S, MacKenzie M, Berkman L, Gupta S, Pramesh CS, Gilbert D, Kynaston H, Cameron D, Wilson RH, Ring A, Langley RE; Add-Aspirin investigators.. | Contemp Clin Trials. 2016 Nov;51:56-64. doi: 10.1016/j.cct.2016.10.004. Epub 2016 Oct 21. | PMID:27777129 | PMCID:PMC5127874 |
10 |
Management of N2 non-small cell lung cancer. | Shetty PS, Mankar H, Pramesh CS. | J Thorac Cardiovasc Surg. 2016 Nov;152(5):1463-1464. doi: 10.1016/j.jtcvs.2016.06.018. No abstract available. | PMID:27751250 |
11 |
Involvement of general public in biomedical research. | Pramesh CS, Venkataramanan R, Suvarna V, Goel NS, Lakshman S, Venkatesh V, Gupta V, Badwe R. | Perspect Clin Res. 2016 Oct-Dec;7(4):152-155. | PMID:27843788 | PMCID:PMC5079086 |
12 |
Pulmonary hemangioendothelioma with osteoclast-like giant cells: A rare observation. | Adamane SA, Deodhar KK, Gupta AM, Karimundackal G, Desai SB. | Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):398-400. doi: 10.4103/0377-4929.188125. | PMID:27510689 |
13 |
Common pitfalls in statistical analysis: Intention-to-treat versus per-protocol analysis. | Ranganathan P, Pramesh CS, Aggarwal R. | Perspect Clin Res. 2016 Jul-Sep;7(3):144-6. doi: 10.4103/2229-3485.184823. | PMID:27453832 | PMCID:PMC4936074 |
14 |
A randomized trial to assess the utility of preintubation adult fiberoptic bronchoscope assessment in patients for thoracic surgery requiring one-lung ventilation. | Amin N, Tarwade P, Shetmahajan M, Pramesh CS, Jiwnani S, Mahajan A, Purandare N. | Ann Card Anaesth. 2016 Apr-Jun;19(2):251-5. doi: 10.4103/0971-9784.179614. | PMID:27052065 | PMCID:PMC4900363 |
15 |
Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage? | Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Agarwal JP, Prabhash K, Noronha V, Joshi A, Kumar R, Rangarajan V. | Indian J Cancer. 2016 Apr-Jun;53(2):270-273. doi: 10.4103/0019-509X.197717. | PMID:28071625 |
16 |
Common pitfalls in statistical analysis: The perils of multiple testing. | Ranganathan P, Pramesh CS, Buyse M. | Perspect Clin Res. 2016 Apr-Jun;7(2):106-7. doi: 10.4103/2229-3485.179436. | PMID:27141478 | PMCID:PMC4840791 |
17 |
Common pitfalls in statistical analysis: Absolute risk reduction, relative risk reduction, and number needed to treat. | Ranganathan P, Pramesh CS, Aggarwal R. | Perspect Clin Res. 2016 Jan-Mar;7(1):51-3. doi: 10.4103/2229-3485.173773. | PMID:26952180 | PMCID:PMC4763519 |
18 |
Common pitfalls in statistical analysis: Odds versus risk. | Ranganathan P, Aggarwal R, Pramesh CS. | Perspect Clin Res. 2015 Oct-Dec;6(4):222-4. doi: 10.4103/2229-3485.167092. | PMID:26623395 | PMCID:PMC4640017 |
19 |
Surgical site infection rates in six cities of India: findings of the International Nosocomial Infection Control Consortium (INICC). | Singh S, Chakravarthy M, Rosenthal VD, Myatra SN, Dwivedy A, Bagasrawala I, Munshi N, Shah S, Panigrahi B, Sood S, Kumar-Nair P, Radhakrishnan K, Gokul BN, Sukanya R, Pushparaj L, Pramesh CS, Shrikhande SV, Gulia A, Puri A, Moiyadi A, Divatia JV, Kelkar R, et al. | Int Health. 2015 Sep;7(5):354-9. doi: 10.1093/inthealth/ihu089. Epub 2014 Dec 8. | PMID:25487724 |
20 |
Global cancer surgery: delivering safe, affordable, and timely cancer surgery. | Sullivan R, Alatise OI, Anderson BO, Audisio R, Autier P, Aggarwal A, Balch C, Brennan MF, Dare A, D'Cruz A, Eggermont AM, Fleming K, Gueye SM, Hagander L, Herrera CA, Holmer H, Ilbawi AM, Jarnheimer A, Ji JF, Kingham TP, Liberman J, Leather AJ, et al. | Lancet Oncol. 2015 Sep;16(11):1193-224. doi: 10.1016/S1470-2045(15)00223-5. Review. | PMID:26427363 |
21 |
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). | Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, DʼJourno XB, Griffin SM, Hölscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJ. | Ann Surg. 2015 Aug;262(2):286-94. doi: 10.1097/SLA.0000000000001098. | PMID:25607756 |
22 |
Giant mediastinal carcinoid. | Jiwnani S, Karimundackal G, Pramesh CS. | Indian J Med Paediatr Oncol. 2015 Jul-Sep;36(3):194. doi: 10.4103/0971-5851.166764. No abstract available. | PMID:26855531 | PMCID:PMC4743190 |
23 |
Institutional external peer review: A unique National Cancer Grid initiative. | Raghunadharao D, Kannan R, Hingnekar C, Vijaykumar DK, Mani CS, Ghosh-Laskar S, Gujral S, Chaudhari S, Nayak S, Dikshit R, Badwe RA, Pramesh CS; National Cancer Grid.. | Indian J Med Paediatr Oncol. 2015 Jul-Sep;36(3):186-8. doi: 10.4103/0971-5851.166753. No abstract available. | PMID:26855528 | PMCID:PMC4743180 |
24 |
Common pitfalls in statistical analysis: Clinical versus statistical significance. | Ranganathan P, Pramesh CS, Buyse M. | Perspect Clin Res. 2015 Jul-Sep;6(3):169-70. doi: 10.4103/2229-3485.159943. | PMID:26229754 | PMCID:PMC4504060 |
25 |
Writing case reports for ecancer. | Ranganathan P, Bavdekar SB, Pramesh CS. | Ecancermedicalscience. 2015 Jun 30;9:ed49. doi: 10.3332/ecancer.2015.ed49. eCollection 2015. No abstract available. | PMID:26180549 | PMCID:PMC4494821 |
26 |
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer. | Lazar V, Rubin E, Depil S, Pawitan Y, Martini JF, Gomez-Navarro J, Yver A, Kan Z, Dry JR, Kehren J, Validire P, Rodon J, Vielh P, Ducreux M, Galbraith S, Lehnert M, Onn A, Berger R, Pierotti MA, Porgador A, Pramesh CS, Ye DW, et al. | Oncotarget. 2015 Jun 10;6(16):14139-52. | PMID:25944621 | PMCID:PMC4546456 |
27 |
An approach of selecting appropriate markers from the primary tumor to enable detection of circulating tumor cells in patients with non-small cell lung cancer. | Warawdekar UM, Sirajuddin MM, Pramesh CS, Mistry RC. | J BUON. 2015 May-Jun;20(3):782-90. | PMID:26214631 |
28 |
Regional variation in identified cancer care needs of early-career oncologists in China, India, and Pakistan. | Lyerly HK, Fawzy MR, Aziz Z, Nair R, Pramesh CS, Parmar V, Parikh PM, Jamal R, Irumnaz A, Ren J, Stockler MR, Abernethy AP. | Oncologist. 2015 May;20(5):532-8. doi: 10.1634/theoncologist.2014-0213. Epub 2015 Apr 17. | PMID:25888267 | PMCID:PMC4425376 |
29 |
Management of esophageal small cell carcinoma. | Purwar P, Jiwnani S, Karimundackal G, Pramesh CS. | Ann Thorac Surg. 2015 Apr;99(4):1488. doi: 10.1016/j.athoracsur.2014.11.029. No abstract available. | PMID:25841845 |
30 |
Primary undifferentiated spindle cell sarcoma of the lung with metastasis to bone--A rare clinical entity with even rarer clinical course. | Gulia A, Puri A, Rekha B, Pramesh CS. | Indian J Cancer. 2015 Apr-Jun;52(2):254-5. doi: 10.4103/0019-509X.175839. No abstract available. | PMID:26853426 |
31 |
Common pitfalls in statistical analysis: "P" values, statistical significance and confidence intervals. | Ranganathan P, Pramesh CS, Buyse M. | Perspect Clin Res. 2015 Apr-Jun;6(2):116-7. doi: 10.4103/2229-3485.154016. | PMID:25878958 | PMCID:PMC4394578 |
32 |
Issues in management of N2 disease in NSCLC. | Kumar T, Jiwnani S, Karimundackal G, Pramesh CS. | Ann Thorac Surg. 2015 Feb;99(2):744-5. doi: 10.1016/j.athoracsur.2014.09.032. No abstract available. | PMID:25639431 |
33 |
Common pitfalls in statistical analysis: "No evidence of effect" versus "evidence of no effect". | Ranganathan P, Pramesh CS, Buyse M. | Perspect Clin Res. 2015 Jan-Mar;6(1):62-3. doi: 10.4103/2229-3485.148821. | PMID:25657905 | PMCID:PMC4314850 |
Lung & Esophagus Cancer Support group meeting: Esophageal and lung cancer support group meeting is held on 4th Tuesday of every month. It has invited talks, discussions focusing on patient-centric problems. The involvement from patients has been encouraging and this provides them a forum for exchange of experiences, discussing their fears, concerns and closer interaction with other patients and their treating physicians. In addition, the availability of dedicated counselors for patients with thoracic cancers and the institution of early palliative care into the treatment continuum are some more initiatives to improve the overall experience for patients.
Department Office Number: (+9122) 24177000 / Ext.No. 7070, 7277, 6667, PA- 6310 /
MOBILE No. SR II/III: 22161, 22404, 22160
Department of Thoracic,
TATA MEMORIAL HOSPITAL, Dr.E.Borges Road, Parel, Mumbai-400-012
Maharashtra, India
Hospital Fax Number: (+9122) 24101656
Email-id: dmgth@tmc.gov.in
About Us
Realizing the increasing need to address the respiratory co-morbidities in cancer, the seed for the Pulmonary Medicine Services was sown in 2006 by Dr. Sandeep Tandon, Pulmonologist and Staff Physician at Tata Memorial Hospital.
What began with a few referrals has exponentially increased to over 6000 consultations annually.
The Department now is constituted by Dr. Tandon, two-part time Pulmonology Consultants and a Post MD (Respiratory Medicine) Senior Registrar.
The Pulmonary Medicine Unit aims at creating a teaching programme that will train future young minds to develop the skills to cater to this ever increasing need for Pulmonologists specializing in management of respiratory diseases that are prevalent and often unique to Cancer patients.
We also aspire to developing research aimed at creating new information that will bolster management of respiratory disorders and strive towards achieving a better quality of life in this group.
The 2 year HBNI fellowship in Onco-Pulmonology has been proposed with this goal in mind.
The Unit has been set up with an aim to increase the scope of diagnostic services offered including EBUS with rapid on-site cytology, medical thoracoscopy and bronchoscopy for pulmonary infections in paediatric age group apart from adults and in intensive care unit, in conjunction with the Department of Thoracic Surgery, Anesthesiology, Interventional Radiology, Microbiology and Pathology thus promoting a multidisciplinary approach.
In the pipe-line is also the plan for setting up a state of the art Airway Management Lab in conjunction with the Department of Thoracic surgical services that will ensure catering to the ever increasing need for palliative relief of airway obstruction in cancer patients.
Outpatient Department
The Pulmonary Medicine Unit runs an Outpatient Department Monday through Friday between 8 AM and 1 PM
The Services essentially include respiratory evaluation of cancer patients referred from Oncology Units at Tata Memorial Hospital
The spectrum includes
Inpatient services
The Pulmonary Medicine Unit attends to the need for respiratory opinion and assistance in management of admitted patients referred from across all oncology departments at Tata Memorial Hospital including the intensive care units.
Procedures
The Pulmonary Medicine Unit has proposed a 2 year academic programme towards Fellowship in Onco-Pulmonology for Chest Physicians through Homi Bhabha National Institute (HBNI) that is currently awaiting approval by the Board of Studies for academic year 2018-2019. The aim of this fellowship is to provide a structured curriculum and training to pulmonologists to enable them to manage pulmonary diseases, complications, co-morbidities and toxicities prevalent in the cancer patient cohort. The planned curriculum will also include training in bronchoscopy, pleural procedures, EBUS and intensive care. The programme also will include a mandatory research topic that hopes to encourage young doctors to conduct respiratory research relevant to the oncology field.
The unit also proposes to have regular academic teaching Chest-Radiology meetings with experts in the field of radiology and relevant clinicians, intensivists and students for multi- disciplinary discussion and approach towards complex respiratory radiology and clinical presentations.
COPD and lung cancer.
Pre-operative respiratory optimization for cancer surgery and its impact on peri-operative respiratory events
Role and yield of EBUS in mediastinal lymphadenopathy
Pulmonary rehabilitation and its impact on QALY in cancer patients with respiratory co-morbidities
Pulmonary infections in patients with cancer and on cancer therapy
Role of newer modalities and therapies for drug induced pulmonary toxicity
Broncho-alveolar lavage and its yield in diagnosis of infections in immune suppressed hosts
Obstructive Sleep Apnea in treated oral cancer patients
Pulmonary Medicine OPD
This is located in the Golden Jubilee Building Basement Room No 13.
OPD timings: Monday to Friday 8 am to 1 pm
Consultations are available for both private as well as general category patients in the same OPD
A prior appointment is necessary for consulting us, both for first time and follow up visits.
Consultations include referrals from within our institution from the various oncology departments. If you wish to consult us, please request your treating doctor at Tata Memorial Hospital to make a formal referral.
If you are diagnosed as having cancer, you will need to see the appropriate oncology department who would refer you to us for a respiratory consult, if required.
Appointments may be taken personally by contacting our secretary at the OPD Counter between 8am to 5pm
Telephonic appointments are possible, please contact the appointment desk at least a week prior to the desired date.
Tata Memorial Hospital Chest Physician OPD: Tel NO: 022-24177000 Extension 4540 between 9 am and 5 pm. Please quote your Hospital File number at the time of taking an appointment
In case you are unable to keep your appointment, kindly call up the above number to cancel the appointment so that another needy patient is not deprived of a consultation.
Typical waiting time for an appointment for a first consult may be 3 to 5 working days and for follow-up consults may be 1 to 3 working days. Consultations without a prior appointment are subject to unforeseen cancellations of prior appointments and availability of time slots.
Patients are requested to please get any prior consultation details, X-rays, CT scans and investigations for review at the time of the OPD visit. This enables us to get a comprehensive view on sequence of medical events that is often a pre-requisite for better understanding and prompt diagnosis of your condition.
Dr Sandeep Tandon completed his MD in Respiratory Medicine from Seth GS Medical College and KEM Hospital in 1994 following which he was Lecturer in Chest Medicine Department at KEM Hospital until 2002. He joined the General Medicine Department of Tata Memorial Hospital in 2002 and from mid- 2006 he has initiated the Pulmonary Medicine OPD and the Pulmonary Medicine Unit as well as taken up additionally the clinical and administrative responsibilities of the Staff Clinic ( Occupational Health Clinic ) as the Staff Physician of Tata Memorial Hospital. He has developed and given shape to the Pulmonary Medicine Unit in its current form.
Dr. Maheema Bhaskar completed her training in Tuberculosis and Respiratory Diseases from Seth G.S. Medical College and KEM Hospital, Mumbai. She has over 12 years of medical teaching experience initially as Assistant Professor at Seth. G.S.M.C and then Associate Professor at L.T.M.M.C and Sion hospital and is keenly interested in developing an academic teaching programme, upscaling paediatric bronchoscopy services and respiratory research.
She is trained in flexible bronchoscopy, EBUS and medical thoracoscopy.
Dr Aparna Iyer completed her training in Tuberculosis and Respiratory Diseases from Seth G.S. Medical College and KEM Hospital, Mumbai. She has over 8 years of medical teaching experience as Assistant Professor at Seth G.S.M.C and Dr. D. Y. Patil Medical College, Navi Mumbai and is keenly interested in developing an academic teaching programme and respiratory research especially in the field of lung cancer.
She has completed her Fellowship in Interventional Pulmonology from Vrije University Medical Center, Amsterdam and is trained in performing EBUS, rigid and flexible bronchoscopy and diagnostic medical thoracoscopy.
TATA MEMORIAL HOSPITAL
Dr. E Borges Road, Parel, Mumbai - 400 012 India
Phone: +91-22- 24177000, 24177300, 24161413
Fax: +91-22-24146937
E-mail : msoffice@tmc.gov.in(for patient care and queries)/cash@tmc.gov.in(for accounts related)/fundraising@tmc.gov.in (for donors and donation related)/registrar@tmc.gov.in(for education and training)/hrd@tmc.gov.in(for administrative - HRD matters) This email address is being protected from spambots. You need JavaScript enabled to view it.
Copyright © 2016 Tata Memorial Centre. All rights reserved.This website can be best viewed in Microsoft Internet Explorer 9.0+, Chrome, Firefox
Designed and Developed by Mindspace Software Technologies Pvt. Ltd.
1165623 (359)